Damora Therapeutics, Inc. (DMRA)
Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Damora Therapeutics, Inc. Ordinary Shares
NASDAQ:DMRAHealthcare · Medical - Pharmaceuticals
-2.36%$21.49
AH$21.49+0.00%vs close
Mkt Cap$1.33B
Float45.93M
O/S61.74M
Vol
$ Vol
RVOL
Inst Own-
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$209.84M
Total Assets$260.53M
Free Cash Flow-$6.73M
Debt & Equity
Debt 0%
Equity 37%
Preferred 63%
Total Debt$68K
Total Equity$240.38M
Preferred Stock$416.25M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in DMRA's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$260.53M
Liabilities$20.15M
Accounts Receivable$899K
Accounts Payable$444K
Inventory$0
PP&E (Net)$104K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $181K | $830K | $490K | $441K | $188K | $111K | $0 |
| Gross Profit | $0 | -$181K | -$830K | -$490K | -$441K | -$188K | -$111K | $0 |
| Gross Margin | - | - | - | - | - | - | - | - |
| Research and Development | $201.19M | $6.4M | $23.77M | $48.21M | $38.49M | $24.63M | $36.53M | $10.09M |
| Selling, General, and Administrative | $9.69M | $10.32M | $11.86M | $12.51M | $13.3M | $8.82M | $2.33M | $2.81M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $210.87M | $16.72M | $35.63M | $60.72M | $51.79M | $33.45M | $38.86M | $12.91M |
| Operating Income (EBIT) | -$210.87M | -$16.9M | -$36.46M | -$61.21M | -$52.23M | -$33.64M | -$38.97M | -$12.91M |
| Operating Margin | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.97M |
| Interest Income | $1.17M | $844K | $1.69M | $722K | $156K | $0 | $0 | $0 |
| Other Income (Expense) | $1.08M | -$4.5M | -$1.89M | -$417K | $475K | -$1.2M | $2.46M | -$2.96M |
| Income Before Tax (EBT) | -$209.79M | -$21.4M | -$38.35M | -$61.62M | -$51.75M | -$34.84M | -$36.51M | -$15.87M |
| Income Tax Expense | $50K | $41K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$209.84M | -$21.44M | -$38.35M | -$61.62M | -$51.75M | -$34.84M | -$36.51M | -$15.87M |
| Net Income Margin | - | - | - | - | - | - | - | - |
| Supplementary Data | ||||||||
| EPS | -152.99 | -18.53 | -36.08 | -60.63 | -51.22 | -34.48 | -41.35 | -18.68 |
| Diluted EPS | -152.99 | -18.53 | -36.08 | -60.63 | -51.22 | -34.48 | -41.35 | -18.68 |
| Weighted Average OS | 1.36M | 1.16M | 1.06M | 1.02M | 1.01M | 1.01M | 1.02M | 1.02M |
| EBITDA | -$209.75M | -$21.22M | -$37.52M | -$61.13M | -$51.31M | -$33.45M | -$38.86M | -$12.91M |
| EBITDA Margin | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $257.62M | $14.18M | $21.46M | $32.79M | $62.56M | $163.58M | $11.29M | $30.99M |
| Short-Term Investments | $0 | $0 | $11.69M | $27.44M | $37.63M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $257.62M | $14.18M | $33.15M | $60.22M | $100.19M | $163.58M | $11.29M | $30.99M |
| Accounts Receivable | $899K | $881K | $1.72M | $1.38M | $2.28M | $2.21M | $41.13M | $989K |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.32M | $1.19M | $1.13M | $1.5M | $5.9M | $1.86M | $3.66M | $2.98M |
| Total Current Assets | $260.42M | $16.84M | $36.77M | $63.91M | $110.1M | $169.29M | $56.08M | $34.96M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $104K | $130K | $325K | $1.17M | $1.04M | $885K | $298K | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $5.83M | $9.05M | $254K | $231K | $144K |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $163K | $1.13M | $2.28M | $2.03M | $1.16M | $0 | $0 |
| Total Long-Term Assets | $104K | $293K | $1.45M | $9.28M | $12.11M | $2.3M | $529K | $144K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $260.53M | $17.13M | $38.23M | $73.19M | $122.22M | $171.6M | $56.61M | $35.1M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $444K | $377K | $1.7M | $3.35M | $1.53M | $2.85M | $3.33M | $1.41M |
| Short-Term Debt | $0 | $12K | $183K | $476K | $399K | $374K | $87K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $1.52M | $604K | $2.96M | $6.68M | $2.01M | $1.31M | $4.4M | $2.88M |
| Total Current Liabilities | $20.07M | $1.2M | $5.83M | $11.11M | $4.54M | $5.57M | $7.93M | $4.44M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $0 | $1.36M | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $28K | $43K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $81K | $1.46M | $66K | $328K | $448K | $541K | $211K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $20.15M | $2.66M | $5.9M | $11.44M | $4.99M | $6.11M | $8.14M | $4.44M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $416.25M | $0 | $0 | $0 | $0 | $0 | $119.62M | $64.5M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$487.36M | -$277.52M | -$256.08M | -$217.74M | -$156.11M | -$104.36M | -$69.52M | -$33.02M |
| Comprehensive Income & Other | $802K | $97K | $380K | -$244K | -$320K | $674K | -$2.45M | -$1.64M |
| Other Stockholders' Equity | $727.74M | $292M | $288.42M | $279.49M | $273.33M | $269.85M | $117.99M | $63.68M |
| Total Equity | $240.38M | $14.47M | $32.33M | $61.75M | $117.22M | $165.49M | $48.47M | $30.66M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $260.53M | $17.13M | $38.23M | $73.19M | $122.22M | $171.6M | $56.61M | $35.1M |
| Supplementary Data | ||||||||
| Total Debt | $68K | $1.43M | $249K | $804K | $847K | $915K | $298K | $0 |
| Net Debt | -$257.56M | -$12.74M | -$21.22M | -$31.98M | -$61.72M | -$162.67M | -$11M | -$30.99M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$209.84M | -$21.44M | -$38.35M | -$61.62M | -$51.75M | -$34.84M | -$36.51M | -$15.87M |
| Depreciation & Amortization | $34K | $181K | $830K | $490K | $441K | $188K | $111K | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $998K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $17.27M | -$1.32M | -$1.65M | $1.82M | -$1.32M | -$477K | $1.94M | $733K |
| Other Working Capital | $1.09M | -$1.34M | -$2.72M | $10.12M | -$5.3M | -$4.11M | $257K | -$1.67M |
| Total Working Capital Change | $18.36M | -$2.67M | -$4.37M | $11.94M | -$6.62M | -$4.59M | $2.19M | -$933K |
| Other Non-Cash Items | $183.72M | $5.3M | $4.98M | $6.26M | $5.63M | $1.04M | $14.88M | $3.11M |
| Net Cash from Operating | -$6.73M | -$18.62M | -$36.91M | -$42.93M | -$52.31M | -$38.2M | -$19.33M | -$13.69M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $0 | -$196K | -$223K | $0 | $0 | $0 |
| Acquisitions | -$17.37M | $0 | $83K | $0 | $0 | $0 | -$326K | $0 |
| Purchases of Investments | $0 | $0 | -$25.94M | -$44.87M | -$84.21M | $0 | $0 | $0 |
| Sales of Investments | $0 | $11.65M | $48.18M | $57.45M | $36.38M | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$17.37M | $11.65M | $22.33M | $12.38M | -$48.05M | $0 | -$326K | $0 |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | - | - | -$8.51M |
| Common Stock Issuance | $0 | $0 | $2.88M | $507K | $0 | $187.39M | $0 | $34.36M |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $33K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Financing | $266.84M | $0 | $2.88M | $507K | $0 | $187.39M | $0 | $42.87M |
| Forex Effect | $705K | -$317K | $384K | $264K | -$663K | $3.1M | -$41K | $1.8M |
| Net Change in Cash | $243.45M | -$7.29M | -$11.32M | -$29.78M | -$101.02M | $152.29M | -$19.69M | $30.99M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$6.73M | -$18.62M | -$36.91M | -$42.93M | -$52.31M | -$38.2M | -$19.33M | -$13.69M |
| Capital Expenditure | $0 | $0 | $0 | -$196K | -$223K | $0 | $0 | $0 |
| Free Cash Flow | -$6.73M | -$18.62M | -$36.91M | -$43.13M | -$52.53M | -$38.2M | -$19.33M | -$13.69M |
| Cash at Beginning | $14.18M | $21.46M | $32.79M | $62.56M | $163.58M | $11.29M | $30.99M | $0 |
| Cash at End | $257.62M | $14.18M | $21.46M | $32.79M | $62.56M | $163.58M | $11.29M | $30.99M |